128 related articles for article (PubMed ID: 340084)
21. Overcoming radioresistance in head and neck squamous cell carcinoma.
Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
[TBL] [Abstract][Full Text] [Related]
22. What can we learn from the hyperbaric oxygen trials in head and neck cancer?
Hartmann KA; Carl UM; Bahnsen J
Strahlenther Onkol; 1996 Nov; 172 Suppl 2():26-7. PubMed ID: 8946043
[No Abstract] [Full Text] [Related]
23. Hyperbaric oxygen in the radiation treatment of head and neck cancers.
Sealy R
Radiother Oncol; 1991; 20 Suppl 1():75-9. PubMed ID: 2020773
[TBL] [Abstract][Full Text] [Related]
24. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
Denekamp J; Harris SR
Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
[No Abstract] [Full Text] [Related]
25. [New results with delayed progression in the cell cycle of solid squamous cell carcinomas of the head-neck area after single and fractionated irradiation with cobalt-60 and neutrons].
Wagner W
Strahlenther Onkol; 1990 Nov; 166(11):722-7. PubMed ID: 2260010
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
[TBL] [Abstract][Full Text] [Related]
27. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Fazekas JT; Goodman RL; McLean CJ
Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
[No Abstract] [Full Text] [Related]
28. Radiotherapy plus chemotherapy for head and neck cancer.
Mendenhall WM; Parsons JT
N Engl J Med; 1993 Feb; 328(8):579-80. PubMed ID: 8489586
[No Abstract] [Full Text] [Related]
29. Radiotherapy plus chemotherapy for head and neck cancer.
Michalski J; Emami B
N Engl J Med; 1993 Feb; 328(8):580. PubMed ID: 8426629
[No Abstract] [Full Text] [Related]
30. Three-year observation of combined treatment for far advanced cancer of the head and neck.
Lipshutz H; Lerner H
Am J Surg; 1969 Nov; 118(5):698-700. PubMed ID: 5347089
[No Abstract] [Full Text] [Related]
31. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
Langer C; Damsker J; Ridge A
Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
[TBL] [Abstract][Full Text] [Related]
33. Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience.
Lee DJ; Phillips TL; Coleman CN; Cosmatos D; Davis LW; Wasserman TH; Marcial VA; Rubin P
Int J Radiat Oncol Biol Phys; 1992; 22(3):569-71. PubMed ID: 1531215
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
Rischin D; Fisher R; Peters L; Corry J; Hicks R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
[No Abstract] [Full Text] [Related]
35. Changing perspectives in oxygen breathing and radiation therapy.
Rubin P; Poulter CA; Quick RS
Am J Roentgenol Radium Ther Nucl Med; 1969 Mar; 105(3):665-81. PubMed ID: 5775023
[No Abstract] [Full Text] [Related]
36. Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials.
Toustrup K; Sørensen BS; Metwally MA; Tramm T; Mortensen LS; Overgaard J; Alsner J
Acta Oncol; 2016; 55(9-10):1091-1098. PubMed ID: 27161763
[TBL] [Abstract][Full Text] [Related]
37. Accelerated repopulation in head and neck cancer.
Withers HR; Maciejewski B; Taylor JM; Hliniak A
Front Radiat Ther Oncol; 1988; 22():105-10. PubMed ID: 3350350
[No Abstract] [Full Text] [Related]
38. Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation.
Friedman M; DeNarvaes FN; Daly JF
Cancer; 1970 Sep; 26(3):711-21. PubMed ID: 5458276
[No Abstract] [Full Text] [Related]
39. Human head and neck squamous cell carcinoma cell lines are differentially radiosensitised by the honeybee product Propolis.
Hehlgans S; Lange I; Eke I; Kammerer B; Cordes N
Int J Radiat Biol; 2011 Mar; 87(3):243-53. PubMed ID: 21142702
[TBL] [Abstract][Full Text] [Related]
40. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
Regine WF; Valentino J; Arnold SM; Haydon RC; Sloan D; Kenady D; Strottmann J; Pulmano C; Mohiuddin M
J Clin Oncol; 2001 Jul; 19(14):3333-9. PubMed ID: 11454880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
